Bio Impact Capital LLC Fulcrum Therapeutics, Inc. Transaction History
Bio Impact Capital LLC
- $611 Million
- Q1 2024
A detailed history of Bio Impact Capital LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 1,137,108 shares of FULC stock, worth $7 Million. This represents 1.76% of its overall portfolio holdings.
Number of Shares
1,137,108Holding current value
$7 Million% of portfolio
1.76%Shares
1 transactions
Others Institutions Holding FULC
# of Institutions
135Shares Held
43.7MCall Options Held
3.12MPut Options Held
128K-
Rtw Investments, LP New York, NY5.85MShares$36 Million0.89% of portfolio
-
Cowen And Company, LLC3.71MShares$22.9 Million1.18% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.85MShares$17.5 Million1.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$15.6 Million0.0% of portfolio
-
Trv Gp Iv, LLC Boston, MA2.34MShares$14.4 Million10.72% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $321M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...